Hot flash score changes from baseline for a series of eight randomized, placebo-controlled trials, plus a trial in which women were randomized to venlafaxine (75 mg/day) versus a single dose (400 mg) of intramuscular medroxyprogesterone acetate. Six week data shown for the latter trial.